Share this article
Share this article
ResearchAndMarkets.com s offering.
The market has just gotten started with a handful of small startup companies. Expect the big players to start taking notice.
CRISPR is not just about changing genes. CRISPR identifies unique genetic material instantly, accurately and cheaply. A whole new world of identification and diagnostics opens up. Find out exactly what kind of cold or flu you have. Find out exactly what kind of fish you are eating. Instantly detect the presence of unwelcome bacteria, anywhere. A new COVID test is already available.
Will this disruptive technology change the world of In Vitro Diagnostics? What is the impact on Clinical Laboratories? How will social norms be affected?
FDA waiver broadens the use of chlamydia and gonorrhea test at more point-of-care settings news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
BOSTON, March 17, 2021 /PRNewswire/ binx health, a population health technology company that provides convenient healthcare solutions, announced today that its FDA emergency-use authorized at-home nasal swab COVID-19 Sample Collection Kit is now available for delivery to Amazon Business customers across the United States. binx health is a proven leader in accurate, convenient testing and is aiming to redefine population health by making health testing more accessible. With its at-home nasal swab COVID-19 Sample Collection Kits now available through Amazon Business, binx health is broadening its ability to support businesses, academic institutions and governments as they work to ensure healthy work and learning environments and mitigate further spread of the virus.
4.2.3 Wellness Hurts
4.3 Diagnostic Technology Development1
4.3.2 NAT vs. Lateral Flow
4.3.3 The Unusual Role of GPS
4.3.4 Self and Send Competition
4.4.5 The Relationship to DTC Genetic
4.4.6 The Relationship to TeleHealth
4.4.7 Sample Collection - Who Knew?
5. OTC/DTC Infectious Disease Testing Recent Developments
Recent Developments - Importance and How to Use This Section
Importance of These Developments
FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit
Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test
Lucira Health Files for $115M IPO
Spectrum Solutions Gets CE Mark for Saliva Collection Devices
Sherlock Biosciences Receives Gates Foundation Grant for COVID-19 Self-Test
LabCorp Receives EUA for OTC COVID-19 Test Home Collection Kit
20
a class=”external” href=”https://www.databridgemarketresearch.com/reports/global-cardiac-point-of-care-testing-kits-market” rel=”nofollow”>Cardiac point of care testing kits market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to grow at a CAGR of 10.10% in the above-mentioned forecast period. Increases incidences of chronic diseases drives the cardiac point of care testing kits market.
The major players covered in the cardiac point of care testing kits market report a
re F. Hoffmann-La Roche Ltd, Abbott, Siemens AG, Beckman Coulter, Inc., BD , Johnson & Johnson Services, Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Medtronic, Accriva Diagnostics, Opti Medical, Sienco, Inc., Alpha Scientific Electronics, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics Inc., bioMérieux SA, Biomerica, Inc., Binx Health, Inc., Alfa Scientific Designs, Inc., Bio-Rad Laboratories,